Renal Function and Effect of Statin Therapy on Cardiovascular Outcomes in Patients Undergoing Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)

被引:30
|
作者
Natsuaki, Masahiro [2 ]
Furukawa, Yutaka [1 ]
Morimoto, Takeshi [4 ]
Sakata, Ryuzo [3 ]
Kimura, Takeshi [2 ]
机构
[1] Gen Hosp, Kobe City Med Ctr, Dept Cardiovasc Med, Kobe, Hyogo, Japan
[2] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan
[3] Kyoto Univ, Dept Cardiovasc Surg, Grad Sch Med, Kyoto, Japan
[4] Kinki Univ, Sch Med, Ctr Gen Internal Med & Emergency Care, Osaka 589, Japan
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 11期
关键词
CHRONIC KIDNEY-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2; DIABETES-MELLITUS; C-REACTIVE PROTEIN; HEART-DISEASE; PREVENTION; EVENTS; ROSUVASTATIN; ATORVASTATIN; HEMODIALYSIS;
D O I
10.1016/j.amjcard.2012.07.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although statin therapy is essential for secondary cardiovascular prevention, the therapeutic effect of statins on cardiovascular outcomes in patients with advanced chronic kidney disease (CKD) after coronary revascularization has not been fully elucidated. In the CREDO-Kyoto Registry Cohort-2, 14,706 patients who underwent first coronary revascularization were divided into 4 strata based on estimated glomerular filtration rate (eGFR) or status of hemodialysis (HD). Patients in each stratum were further divided into 2 groups based on statin therapy at discharge: non-CKD stratum (eGFR >= 60 ml/min/1.73 m(2)), 8,959 patients (statin, n = 4,747; no statin, n = 4,212); mild CKD stratum (eGFR >= 30 to <60 ml/min/1.73 m(2)), 4,567 patients (statin, n = 2,135; no statin, n = 2,432); severe CKD stratum (eGFR <30 ml/min/1.73 m(2)), 608 patients (statin, n = 229; no statin, n = 379); and HD stratum, 572 patients (statin, n = 117; no statin, n = 455). Median follow-up duration was 956 days (interquartile range 699 to 1,245). Adjusted risk for major adverse cardiovascular events (MACEs; composite of cardiovascular death, myocardial infarction, or stoke) was significantly lower in the statin group than in the no-statin group in the non-CKD (hazard ratio 0.8, 95% confidence interval 0.68 to 0.95, p = 0.01) and mild CKD (hazard ratio 0.69, 95% confidence interval 0.56 to 0.84, p = 0.0002) strata. However, a significant association of statin therapy and lower risk for MACEs was not seen in the severe CKD (hazard ratio 0.91, 95% confidence interval 0.6 to 1.38, p = 0.65) and HD (hazard ratio 1.04, 95% confidence interval 0.64 to 1.69, p = 0.87) strata. In conclusion, statin therapy was associated with significantly lower risk for MACEs in patients with non-CKD and mild CKD undergoing coronary revascularization. However, therapeutic benefits of statins were not apparent in patients with severe CKD and HD. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:1568-1577)
引用
收藏
页码:1568 / 1577
页数:10
相关论文
共 50 条
  • [21] Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1,-2, and-3)
    Shiomi, Hiroki
    Morimoto, Takeshi
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kadota, Kazushige
    Yoshikawa, Yusuke
    Yamaji, Kyohei
    Tada, Tomohisa
    Tazaki, Junichi
    Ehara, Natsuhiko
    Taniguchi, Ryoji
    Tamura, Toshihiro
    Iwakura, Atsushi
    Tada, Takeshi
    Watanabe, Hirotoshi
    Suwa, Satoru
    Toyofuku, Mamoru
    Inada, Tsukasa
    Kaneda, Kazuhisa
    Ogawa, Tatsuya
    Takeda, Teruki
    Sakai, Hiroshi
    Yamamoto, Takashi
    Tambara, Keiichi
    Esaki, Jiro
    Eizawa, Hiroshi
    Yamada, Miho
    Shinoda, Eiji
    Nishizawa, Junichiro
    Mabuchi, Hiroshi
    Tamura, Nobushige
    Shirotani, Manabu
    Nakayama, Shogo
    Uegaito, Takashi
    Matsuda, Mitsuo
    Takahashi, Mamoru
    Inoko, Moriaki
    Kanemitsu, Naoki
    Tamura, Takashi
    Ishii, Kazuhisa
    Nawada, Ryuzo
    Onodera, Tomoya
    Ohno, Nobuhisa
    Koyama, Tadaaki
    Tsuneyoshi, Hiroshi
    Sakamoto, Hiroki
    Aoyama, Takeshi
    Miki, Shinji
    Tanaka, Masaru
    Sato, Yukihito
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 153 : 20 - 29
  • [22] Better Survival With Statin Administration After Revascularization Therapy in Japanese Patients With Coronary Artery Disease - Perspectives From the CREDO-Kyoto Registry
    Furukawa, Yutaka
    Taniguchi, Ryoji
    Ehara, Natsuhiko
    Ozasa, Neiko
    Haruna, Yoshisumi
    Saito, Naritatsu
    Doi, Takahiro
    Hoshino, Kozo
    Shizuta, Satoshi
    Morimoto, Takeshi
    Imai, Yukiko
    Teramukai, Satoshi
    Fukushima, Masanori
    Kita, Toru
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2008, 72 (12) : 1937 - 1945
  • [23] Incidence and Outcome of Surgical Procedures After Coronary Bare-Metal and Drug-Eluting Stent Implantation A Report From the CREDO-Kyoto PCI/CABG Registry Cohort-2
    Tokushige, Akihiro
    Shiomi, Hiroki
    Morimoto, Takeshi
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kadota, Kazushige
    Iwabuchi, Masashi
    Shizuta, Satoshi
    Tada, Tomohisa
    Tazaki, Junichi
    Kato, Yoshihiro
    Hayano, Mamoru
    Abe, Mitsuru
    Ehara, Natsuhiko
    Inada, Tsukasa
    Kaburagi, Satoshi
    Hamasaki, Shuichi
    Tei, Chuwa
    Nakashima, Hitoshi
    Ogawa, Hisao
    Tatami, Ryozo
    Suwa, Satoru
    Takizawa, Akinori
    Nohara, Ryuji
    Fujiwara, Hisayoshi
    Mitsudo, Kazuaki
    Nobuyoshi, Masakiyo
    Kita, Toru
    Kimura, Takeshi
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (02) : 237 - 246
  • [24] Risk of bleeding among diabetic patients treated with drug-eluting stents for coronary artery disease: 5-year results from CREDO-Kyoto PCI/CABG Registry Cohort-2
    Tada, Tomohisa
    Furukawa, Yutaka
    Kadota, Kazushige
    Kimura, Takeshi
    Nakagawa, Yoshihisa
    Ono, Koh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B93 - B94
  • [25] Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2
    Tazaki, Junichi
    Shiomi, Hiroki
    Morimoto, Takeshi
    Imai, Masao
    Yamaji, Kyohei
    Sakata, Ryuzo
    Okabayashi, Hitoshi
    Hanyu, Michiya
    Shimamoto, Mitsuomi
    Nishiwaki, Noboru
    Komiya, Tatsuhiko
    Kimura, Takeshi
    EUROINTERVENTION, 2013, 9 (04) : 437 - 445
  • [26] Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusion: from the CREDO-Kyoto registry Cohort-2
    Yamamoto, E.
    Natsuaki, M.
    Shiomi, H.
    Shizuta, S.
    Morimoto, T.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 966 - 966
  • [27] Duration of Dual Antiplatelet Therapy and Long-Term Clinical Outcome After Coronary Drug-Eluting Stent Implantation Landmark Analyses From the CREDO-Kyoto PCI/CABG Registry Cohort-2
    Tada, Tomohisa
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Byrne, Robert A.
    Kastrati, Adnan
    Kadota, Kazushige
    Iwabuchi, Masashi
    Shizuta, Satoshi
    Tazaki, Junichi
    Shiomi, Hiroki
    Abe, Mitsuru
    Ehara, Natsuhiko
    Mizoguchi, Tetsu
    Mitsuoka, Hirokazu
    Inada, Tsukasa
    Araki, Makoto
    Kaburagi, Satoshi
    Taniguchi, Ryoji
    Eizawa, Hiroshi
    Nakano, Akira
    Suwa, Satoru
    Takizawa, Akinori
    Nohara, Ryuji
    Fujiwara, Hisayoshi
    Mitsudo, Kazuaki
    Nobuyoshi, Masakiyo
    Kita, Toru
    Kimura, Takeshi
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (03) : 381 - 391
  • [28] Comparison of Five-Year Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Left Ventricular Ejection Fractions ≤50% Versus &gt;50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)
    Marui, Akira
    Kimura, Takeshi
    Nishiwaki, Noboru
    Mitsudo, Kazuaki
    Komiya, Tatsuhiko
    Hanyu, Michiya
    Shiomi, Hiroki
    Tanaka, Shiro
    Sakata, Ryuzo
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (07): : 988 - 996
  • [29] Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan-From the CREDO-Kyoto Registry Cohort-2 and Cohort-3
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Shiomi, Hiroki
    Yamamoto, Ko
    Yamaji, Kyohei
    Watanabe, Hirotoshi
    Uegaito, Takashi
    Matsuda, Mitsuo
    Tamura, Toshihiro
    Taniguchi, Ryoji
    Inoko, Moriaki
    Mabuchi, Hiroshi
    Takeda, Teruki
    Domei, Takenori
    Shirotani, Manabu
    Ehara, Natsuhiko
    Eizawa, Hiroshi
    Ishii, Katsuhisa
    Tanaka, Masaru
    Inada, Tsukasa
    Onodera, Tomoya
    Nawada, Ryuzo
    Shinoda, Eiji
    Yamada, Miho
    Yamamoto, Takashi
    Sakai, Hiroshi
    Toyofuku, Mamoru
    Tamura, Takashi
    Takahashi, Mamoru
    Tada, Tomohisa
    Sakamoto, Hiroki
    Tada, Takeshi
    Kaneda, Kazuhisa
    Miki, Shinji
    Aoyama, Takeshi
    Suwa, Satoru
    Sato, Yukihito
    Ando, Kenji
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kadota, Kazushige
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2022, 86 (05) : 748 - +
  • [30] Risk factor profile and the predictors of cardiovascular events in young Japanese patients undergoing first coronary revascularization: Perspectives from CREDO-Kyoto registry
    Furukawa, Yutaka
    Doi, Takahiro
    Saito, Naritatsu
    Ozasa, Neiko
    Shizuta, Satoshi
    Miura, Akira
    Kotoura, Hajime
    Aota, Masaki
    Lee, Jong-Dae
    Tanaka, Kuniyoshi
    Kato, Hiroshi
    Takahashi, Masaaki
    Miki, Izumi
    Hibi, Chikako
    Morimoto, Takeshi
    Teramukai, Satoshi
    Fukushima, Masanori
    Kita, Toru
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A354 - A354